SGS Life Sciences Services to host 4th Antwerp Biopharm Seminar on clinical trial solutions

The one-day conference, entitled “Safety and Efficacy — Clinical Trials Solutions”, will bring together experts from SGS Life Services and the wider pharmaceutical industry, to discuss advances in biopharmaceutical research and development and combine a number of scientific talks, case studies and face-to-face meetings to highlight the most recent solutions in clinical development optimization.

Joining SGS Life Science Services experts will be Ingeborg Heirman, Business Development Manager of VIB vzw, who will explain the role VIB plays in bridging academia with pharma/biotech companies and clinical research organizations, to further development of innovative drugs and biomarkers/diagnostic assays; Gary Kay, CEO of Cognitive Research Corporation, who will present on the 2015 FDA Draft Guidance on evaluating drug effects on driving; and Dr Jean François Rossignol, co-founder, Chief Scientific Officer and Chairman of Romark Laboratories, who will present a case study on influenza vaccine development. A tour of SGS Life Science Services’ Clinical Pharmacology Unit will be organized following the closing remarks. “The clinical research field has many challenges and opportunities which face both sponsors and service providers,” commented Jean-Luc Marsat, Business Manager at SGS Life Science Services. “By bringing together our clients and leading industry experts, and sharing experiences and knowledge in an open forum, we aim to give valuable insight into new trends and practices in biopharmaceutical research and development from a wide range of industry perspectives.”